-
Article
Open AccessComparison of an automated smartphone-based smoking cessation intervention versus standard quitline-delivered treatment among underserved smokers: protocol for a randomized controlled trial
Smoking is the leading cause of preventable morbidity and mortality in the United States. Individuals with low socioeconomic status have disproportionately high smoking rates and greater difficulty quitting sm...
-
Article
A Systematic Review of Economic and Quality-of-Life Research in Carcinoid Syndrome
To date, the economic burden and patient-reported outcomes associated with carcinoid syndrome (CS) in patients with neuroendocrine tumor (NET) remain largely unknown.
-
Article
The impact of co-surgeons on complication rates and healthcare cost in patients undergoing microsurgical breast reconstruction: analysis of 8680 patients
The use of two operating microsurgeons has been shown to improve the efficiency and reduce the operative duration of microsurgical breast reconstruction (MSBR). However, the impact of this practice on healthca...
-
Article
Rising Economic Burden of Renal Cell Carcinoma among Elderly Patients in the USA: Part II—An Updated Analysis of SEER-Medicare Data
The influx of new oncologic technologies has changed the treatment landscape of renal cell carcincoma (RCC) in the last decade. This study updated a previously published paper on the economic burden of RCC in ...
-
Article
Economic Burden of Renal Cell Carcinoma—Part I: An Updated Review
The economic burden of renal cell carcinoma (RCC) had been reported to be significant in a previous review published in 2011.
-
Article
Cost and efficacy comparison of five prostate biopsy modalities: a platform for integrating cost into novel-platform comparative research
The cornerstone of prostate cancer diagnosis remains the transrectal ultrasound-guided biopsy (TRUS-BX), which most frequently occurs in the office setting under local anesthesia. However, there are now other ...
-
Article
Costs of Cancer Care for Elderly Patients with Neuroendocrine Tumors
The incidence and prevalence of neuroendocrine tumors (NETs) have been steadily rising. NETs can arise in various parts of the body and have distinct pathogenesis, clinical manifestations, treatment, and survi...
-
Article
Price Transparency for Whom? In Search of Out-of-Pocket Cost Estimates to Facilitate Cost Communication in Cancer Care
-
Chapter
Lymphedema Within the Healthcare System
Lymphedema impacts psychological, psychosocial, and physiological aspects in the person experiencing this chronic condition. Lymphedema symptoms and the burden of their management further exact an economic tol...
-
Article
Regression-Based Approaches to Patient-Centered Cost-Effectiveness Analysis
Achieving comprehensive patient centricity in cost-effectiveness analyses (CEAs) requires a statistical approach that accounts for patients’ preferences and clinical and demographic characteristics. Increased ...
-
Article
Post-mastectomy breast reconstruction and its subsequent complications: a comparison between obese and non-obese women with breast cancer
To compare the utilization pattern of breast reconstruction between obese and non-obese patients and assess the association between obesity and postoperative complications as well as healthcare costs. Using Ma...
-
Article
The Association between Patient-Centered Attributes of Care and Patient Satisfaction
Little is known about the attributes of care that most strongly impact satisfaction in real-world settings where patients’ limited medical knowledge may restrict their ability to ascertain the true quality of ...
-
Article
Cost-Effectiveness Analyses of Targeted Oral Anti-Cancer Drugs: A Systematic Review
Over the last 15 years, a paradigm shift in oncology has led to the approval of dozens of targeted oral anti-cancer medications (OAMs), which have become the standard of care for certain cancers. While more co...
-
Article
First do no harm: population-based study shows non-evidence-based trastuzumab prescription may harm elderly women with breast cancer
Trastuzumab, although cardiotoxic, is associated with improved survival in HER2-positive breast cancer. Non-compliance with HER2 testing guidelines before prescribing trastuzumab occurs in practice; however, t...
-
Article
A Cost-Effectiveness Analysis of First-Line Controller Therapies for Persistent Asthma
Asthma is one of the most common chronic diseases in the US, and its prevalence continues to increase. Despite the availability of effective asthma controller medications, many patients with asthma are still n...
-
Article
Do Pharmacogenomic Tests Provide Value to Policy Makers?
-
Article
The Association between Symptom Burdens and Utility in Chinese Cancer Patients
This study explored the relationship between the M. D. Anderson Symptom Inventory (MDASI), an instrument measuring the severity of symptoms common to patients with cancer, and utility derived from the SF-36.
-
Article
The economic burden of supportive care of cancer patients
Economic and regulatory healthcare policy is limited by the lack of population-based information on the cost of supportive care of cancer patients. The goal of this study was to estimate these costs and to exp...
-
Article
A Review of Self-Report Instruments Measuring Health-Related Work Productivity
Health impairment often leads to work impairment in the form of both absenteeism and presenteeism (i.e. reduced productivity while at work). Several self-report productivity instruments have been designed over...
-
Article
Resource Utilization Associated with Irritable Bowel Syndrome in the United States: 1987–1997
This study uses national databases to examine the impact of irritable bowel syndrome (IBS) on resource utilization in the United States. Approximately 1.5–2.7 million physician visits (599–1043 per 100,000) ye...
